Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 51–100 of 191 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06672575	A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma	recruiting	Phase 1 / Phase 2	45	M.D. Anderson Cancer CenterOTHER	1	Jul 21, 2026	clinicaltrials
NCT05278208	Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors	recruiting	Phase 1 / Phase 2	65	Nationwide Children's HospitalOTHER	1	Jul 20, 2026	clinicaltrials